Jim Phillips, chief executive of Midatech Pharma (LON:MTPH), says eye-disease drug OpsiSporin is on an accelerated programme in terms of investment priorities after it showed ‘exceedingly...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
http://ift.tt/1GSlkyR @MasterMetals MasterMetals Blog
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
http://ift.tt/1GSlkyR @MasterMetals MasterMetals Blog
No comments:
Post a Comment
Commented on MasterMetals